VGXI Blog & News
Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new Chief Accounting Officer. VGXI, Inc.,[...]
Read MoreVGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization
Plasmids are small, circular, double-stranded DNA molecules that have become indispensable tools in the life sciences. They are primarily found[...]
Read MoreVGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief Commercial Officer. VGXI Inc.,[...]
Read MoreVGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility
With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract manufacturer VGXI, Inc. celebrated the official Grand[...]
Read MoreAn Introduction to DNA and Vaccines
Vaccines are one of humanity’s most important inventions as they help protect public health and save millions of lives every[...]
Read MoreVGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility
Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded[...]
Read MoreVGXI Celebrates First Look Event at New Manufacturing Facility
VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide friends and employee families a[...]
Read MoreVGXI Official COVID-19 Statement
To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and[...]
Read MoreVGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease
Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for Molecular Medicine, has recently been awarded[...]
Read More